IRadimed Corp (IRMD) Mentioned Positively at Roth Capital, 'Solid Fundamentals'
Tweet Send to a Friend
Roth Capital analyst Scott R. Henry lowered the price target on IRadimed Corp (NASDAQ: IRMD) to $40.00 (from $53.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
